Senior Biostatistics Director – Disease Area Lead
Enregistrez cette offre et organisez votre recherche
Créez un compte gratuit pour enregistrer des offres d'emploi, créer des alertes et revenir à cette liste depuis votre tableau de bord.
En continuant, vous acceptez nos Conditions d’utilisation & Politique de confidentialité.
argenx SE is seeking a Disease Area Lead Statistician to steer statistical strategy across Early Development, Research & Discovery and Clinical Development. You will lead a team of biostatisticians, shaping analyses, interpretation, and reporting for multiple assets and indications throughout the product lifecycle.
You will collaborate with QS and other functions, drive innovative statistical methods, manage CROs, and ensure regulatory alignment and timely deliverables in a fast-growing biotech
-
Disease Area Lead Statistician — Biostatistics Director
Il y a 4 jours
Oost-Vlaanderen, Oost-Vlaanderen, Belgique Argenx Temps plein 110 000 € - 160 000 € ContratArgenx is seeking a Disease Area Lead Statistician to steer strategic statistical direction across Early Development, Research & Discovery and Clinical Development. You will lead a biostatistics team, enable data-driven decision making, and collaborate with cross-functional drug development scientists.Reporting to the Head of Biostatistics & Statistical...
-
Biostatistical Director
Il y a 4 jours
Oost-Vlaanderen, Oost-Vlaanderen, Belgique argenx SE Temps plein 120 000 € - 180 000 € ContratJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...
-
Biostatistical Director
Il y a 4 jours
Oost-Vlaanderen, Oost-Vlaanderen, Belgique Argenx Temps plein 110 000 € - 160 000 € ContratJoin us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to...
-
PhD/Post-doctoral
Il y a 3 jours
Oost-Vlaanderen, Oost-Vlaanderen, Belgique VIB.AI Télétravail Temps plein 32 000 € - 42 000 € ContratVIB Center for AI & Computational Biology Centers At VIBPhD/Postdoc in In Vivo CRISPR Screening (Dry and/or Wet Lab)VIB Center for AI & Computational Biology Ghent PhD/Post-doctoralThe Laboratory of Causal Systems Immunology combines causal inference, probabilistic AI and large-scale in vivo perturbation experiments to uncover how genes shape immune-cell...